Keywords: expanded, use, backing, visudyne, fda, novartis, ophthalmics

Expanded use backing on Visudyne from FDA

Article | 05 February 2001

Print This

Novartis Ophthalmics, the eye health unit of Novartis AG, and Canadianfirm QLT Inc, have said that the US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in